Dimensional Fund Advisors
CERE

Dimensional Fund Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Dimensional Fund Advisors’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,682
Closed -$478K – 3416
2024
Q2 		$478K Sell
11,682
-263
-2% -$11K ﹤0.01% 3033
2024
Q1 		$505K Buy
+11,945
New +$502K ﹤0.01% 3042

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Dimensional Fund Advisors's CERE Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 11,682 shares — an estimated $478K sold.

Dimensional Fund Advisors first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $505K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,682 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $478K.
  • Dimensional Fund Advisors first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Dimensional Fund Advisors's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $505K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.